Valdés RER, Álvarez AA

Language: Spanish
References: 20
Page:
PDF size: 196.18 Kb.

ABSTRACT

Introduction: in people with diabetes mellitus, ischemic heart disease shows morbidity and mortality 2-4 times higher than that observed in the general population.
Objective: to describe the clinical characteristics of patients with diabetes mellitus complicated by ischemic heart disease.
Methods: a descriptive cross-sectional study was carried out in 459 patients with diabetes mellitus, treated at the Endocrinology and Cardiology services of the "Carlos Manuel de Céspedes" Provincial General Hospital of the Bayamo municipality, Granma province, since January 1, 2015. until December 31, 2020. Statisticians: Chi Square and Student's T.
Results: the frequency of arterial hypertension (0.0000), left ventricular hypertrophy (0.0000), smoking (0.0128) and other vascular complications of diabetes was higher in patients with ischemic heart disease than in those without have this complication. Likewise, the cases with ischemic heart disease exhibited an age (0.0000), a time of DM (0.0000) and levels of HA1c (0.0002), cholesterol (0.0266), triglycerides (0.0432), ratio cholesterol/HDL (0.0001), microalbuminuria (0.0000) and uric acid (0.0000), significantly higher than those without ischemic heart disease.
Conclusions: patients with diabetes complicated by ischemic heart disease have a higher frequency of cardiovascular risk factors than those without this complication. Other research is necessary to determine the role of these factors in the development of the disease.

REFERENCES

1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157:107843-53.

2. Cuba. Ministerio de Salud Pública. Anuario Estadístico de Salud 2019. La Habana: MINSAP; 2020.

3. Roth GA, Johnson C, Abajobir A, abdallah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol 2017; 70(1): 1-25.

4. Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019; 62(1):3-16.

5. Thygesen K, Alpert J, Jaffe A, Chaitman B, Bax J, David A, et al. Consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio. Rev Esp Cardiol 2019; 72(1):72.e1-72.e27.

6. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck Brentano C, et al. Guía ESC 2019 sobre el diagnóstico y tratamiento de los síndromes coronarios crónicos. Rev Esp Cardiol. 2020; 73(6): 495.e1-495.e61.

7. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetesd 2019. Diabetes Care 2019; 42(Suppl.1):S13-S28.

8. Carrera Y. Cuestionario Internacional de actividad física. Revista Enfermería del Trabajo 2017; 7(2):49-54.

9. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial. Rev cubana med 2017; 56(4):242-321.

10. World Health Organization. Physical Status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Genova: WHO; 1995.

11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-97.

12. Valdés Ramos E, Álvarez Aliaga A, Valdés Bencosme E, Valdés Bencosme N. Enfermedad cardiovascular aterosclerótica según el sexo en personas de edad mediana con diabetes mellitus. Rev Cubana Endocrinol. [Internet]. 2021 [citado 9/12/2021]; 32(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-2953202100020000112. .

13. Sliwinska Mosson M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diab Vasc Dis Res 2017;14: 265-76.

14. Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Over view and meta-analyses of randomized trials. J Hypertens 2017; 35:922-44.

15. Chao Pereira C, Perez Goelkel SJ, Gutierrez Rojas AR, Rosello Azcanio Y. Índice de masa corporal y mortalidad en pacientes diabéticos tipo 2 con insuficiencia cardiaca. Rev Cubana Cardiol Cir Cardiovas 2020; 26(2):1-7.

16. Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalán R, Spinar J, et al. Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation 2018; 137:1571-82.

17. Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019; 42(3):416-26.

18. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41(2):255-323.

19. Valdés Ramos E, Camps Arjona MC. Características clínicas y frecuencia de complicaciones crónicas en personas con diabetes mellitus tipo 2 de diagnóstico reciente. Rev Cubana Med Gen Integr 2013; 29(2): 121-31.

20. Visseren F, Mach F, Smulders Y, Carballo D, Koskinas K, Bäck N, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42(34):3227-337.